Suppr超能文献

新冠疫情对中国惠州市急性缺血性脑卒中患者再灌注治疗的影响。

Effects of the COVID-19 pandemic on reperfusion therapy for acute ischemic stroke patients in Huizhou City, China.

机构信息

Department of Neurology, Huizhou Municipal Central Hospital, No. 41, Eling North Road, Huizhou, 516001, Guangdong Province, People's Republic of China.

Guangdong Medical University, Zhanjiang, Guangdong Province, People's Republic of China.

出版信息

Neurol Sci. 2021 Feb;42(2):467-473. doi: 10.1007/s10072-020-04938-w. Epub 2021 Jan 7.

Abstract

BACKGROUND AND PURPOSE

The COVID-19 pandemic has impacted the reperfusion therapy for acute ischemic stroke (AIS) patients. Huizhou City utilized its experience with the SARS and MERS breakouts to establish a reperfusion treatment program for AIS patients.

METHOD

This is a retrospective study on 8 certified stroke hospitals in Huizhou City from January 2020 to May 2020. We analyzed the number of AIS patients with reperfusion therapy, stroke type (anterior/posterior circulation stroke), modes of transport to hospital, NIHSS score, onset to door time (ODT), door to needle time (DNT), and door to puncture time (DPT). The analysis was compared with baseline data from the same time period in 2019.

RESULT

In 2020, the number of AIS patients receiving reperfusion therapy decreased (315 vs. 377), NIHSS score increased [8 (4, 15) vs. 7 [ (1, 2)], P = 0.024], ODT increased [126 (67.5, 210.0) vs. 120.0 (64.0, 179.0), P = 0.032], and DNT decreased [40 (32.5, 55) vs. 48 (36, 59), P = 0.003]. DPT did not change. Seventy percent of AIS patients indicated self-visit as their main mode of transport to the hospital. In both periods, mild stroke patients were more likely to self-visit than utilize emergency systems [2019: 152 (57.6%) vs. 20 (45.6%), P = 0.034; 2020: 123 (56.9%) vs. 5 (14.7%), P < 0.001]. The NIHSS score for self-visiting patients was lower for patients who utilized the ambulance system in both years [self-visit: 6.00 (3.00, 12.00), ambulance: 14.00 (9.00, 19.00), P < 0.001]. The volume of reperfusion patients was lower in 2020; however, the decrease was only significant (P = 0.028) in February 2020.

CONCLUSION

During the COVID-19 pandemic in 2020, the number of AIS patients receiving reperfusion therapy significantly decreased when compared to the same period in 2019. The patients' condition increased severity, ODT increased, and the DNT decreased. DPT was not significant for self-visiting and ambulance patients. Moderate to severe stroke patients were more likely to utilize ambulance services.

摘要

背景与目的

COVID-19 大流行影响了急性缺血性脑卒中(AIS)患者的再灌注治疗。惠州市利用其在 SARS 和 MERS 爆发期间的经验,为 AIS 患者建立了再灌注治疗方案。

方法

这是一项对 2020 年 1 月至 2020 年 5 月惠州市 8 家认证卒中医院的回顾性研究。我们分析了接受再灌注治疗的 AIS 患者数量、卒中类型(前循环/后循环卒中)、到医院的交通方式、NIHSS 评分、发病至到院时间(ODT)、到针时间(DNT)和到穿刺时间(DPT)。将这些数据与 2019 年同期的基线数据进行比较。

结果

2020 年,接受再灌注治疗的 AIS 患者数量减少(315 例比 377 例),NIHSS 评分增加[8(4,15)比 7 [(1,2)],P=0.024],ODT 增加[126(67.5,210.0)比 120.0(64.0,179.0),P=0.032],DNT 减少[40(32.5,55)比 48(36,59),P=0.003]。DPT 没有变化。70%的 AIS 患者表示自行就诊是他们到医院的主要交通方式。在两个时期,轻度卒中患者更有可能自行就诊而不是利用紧急系统[2019 年:152(57.6%)比 20(45.6%),P=0.034;2020 年:123(56.9%)比 5(14.7%),P<0.001]。在这两年中,利用救护车系统的自行就诊患者的 NIHSS 评分较低[自行就诊:6.00(3.00,12.00),救护车:14.00(9.00,19.00),P<0.001]。2020 年接受再灌注治疗的 AIS 患者数量较低;然而,只有 2020 年 2 月的下降具有统计学意义(P=0.028)。

结论

在 2020 年 COVID-19 大流行期间,与 2019 年同期相比,接受再灌注治疗的 AIS 患者数量显著减少。患者的病情加重,ODT 延长,DNT 缩短。对于自行就诊和救护车患者,DPT 没有显著差异。中重度卒中患者更有可能使用救护车服务。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fdc/7787931/c7a8a074d911/10072_2020_4938_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验